Area of research
Otorhinolaryngology · Oncology
Research interest
Research interests include Medicine, Open label, Nasopharyngeal carcinoma, Capecitabine, Adjuvant, and Cisplatin.
Lactylome Reprogramming Mediates Therapeutic Response and Adaptation to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
Immunological synapse: structures, molecular mechanisms and therapeutic implications in disease
HDAC2‐Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple‐Negative Breast Cancer
Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis
The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities
Deciphering the Metabolic Impact and Clinical Relevance of N‐Glycosylation in Colorectal Cancer through Comprehensive Glycoproteomic Profiling
Highly Sensitive Flow Cytometry Biosensor with a High Signal-to-Background Ratio for FEN1 Analysis via Solid-Phase Interface-Mediated Primer Exchange Reaction Amplification
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration
A multiregional, randomized, controlled, open-label, phase 3 study of the anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) arcotatug tavatecan (IBI343) in gastric or gastroesophageal junction adenocarcinoma (G/GEJA): Trial in progress.
Cardiovascular toxicity of tisagenlecleucel in children and adolescents: analysis of spontaneous reports submitted to FAERS
The role and prognostic value of PANoptosis-related genes in skin cutaneous melanoma
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Advancing In-Depth N-Terminomics Detection with a Cleavable 2-Pyridinecarboxyaldehyde Probe
Polyamine Anabolism Promotes Chemotherapy‐Induced Breast Cancer Stem Cell Enrichment
Ivonescimab Plus Chemotherapy in Patients With <i>EGFR</i> Variant Non–Small Cell Lung Cancer
Artificial intelligence identifies spatial fingerprints of kidney-resident macrophages and brain microglia
Recent advances in targeted strategies for triple-negative breast cancer
Exploiting innate immunity for cancer immunotherapy
Focal adhesion kinase: from biological functions to therapeutic strategies
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era
Retinal determination gene networks: from biological functions to therapeutic strategies
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Potentially improved response of COVID-19 vaccinated nasopharyngeal cancer patients to combination therapy with anti-PD-1 blockade and chemotherapy
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial